At NIH, what tends to happen is that the proven researchers tend to get the money. New researchers, younger researchers, or people on the cutting edge don't get the money until they have gray beards. ↗
Now, what tends to happen is that the stories get hyped. And the medicines are not quite as revolutionary and as dramatic as they seem to be. But, certainly, various phases of this problem are being attacked by the pharmaceutical companies. ↗